Events ❯ Conferences ❯ Medical Conferences

World Conference on Lung Cancer

Amivantamab Plus Chemotherapy Shows Longest Survival for EGFR Exon 20 Insertion Lung Cancer

A prespecified statistical adjustment for on‑protocol crossover produced a significant survival advantage, a result that could shape first‑line treatment choices.

4 ARTICLES

last yr.

B7-H3 ADC Ifinatamab Deruxtecan Shows 48% Response in Relapsed ES-SCLC in Phase 2

5 ARTICLES

last yr.

Iza-Bren Plus Osimertinib Delivers 100% Response in Small First-Line EGFR-Mutant NSCLC Cohort